DKSH and Standard BioTools Announce Distribution Partnership to Expand Spatial Biology and Proteomics Solutions in Australia and New Zealand
DKSH has entered a distribution partnership with Standard BioTools to expand access to advanced spatial biology, proteomics and genomics solutions for researchers across Australia and New Zealand.
Melbourne, Australia – DKSH, a leading provider of Market Expansion Services, has announced a new distribution agreement with Standard BioTools Inc. Under the agreement, DKSH will provide sales, distribution, applications and after-sales support for the Standard BioTools™ product portfolio across Australia and New Zealand.
Headquartered in Boston, Massachusetts, Standard BioTools is a leading provider of mass cytometry and microfluidics technologies, delivering innovative instrumentation and consumables that enable highly multiplexed protein and genomic analysis, including spatial biology and multi-omics workflows. The company’s instruments and consumables support research and translational applications across areas including immunology, oncology and neuroscience.
Through the partnership, DKSH will support Standard BioTools’ growth in the region by leveraging its established local presence, experienced Life Science Instrumentation team, and strong customer relationships across academia, core facilities, pharmaceutical and biotechnology institutions. By combining DKSH’s applications expertise with Standard BioTools’ complementary technology portfolio, the collaboration aims to deliver integrated workflow solutions and enhanced support for spatial biology and proteomics researchers in ANZ.
“DKSH’s strong market knowledge, established customer connections and demonstrated experience in spatial biology made them a natural partner for our expansion in Australia and New Zealand,” said Oliver Vasilevski, PhD, Senior Director – Commercial Operations, Greater Asia, Standard BioTools. “We look forward to working together to provide researchers with greater access to our technologies, supported by high-quality local service and applications expertise.”
“We are proud to partner with Standard BioTools to support their customers in Australia and New Zealand with advanced spatial biology automation solutions”, said Dr Richard Speight, General Manager, Technology, DKSH Australia and New Zealand. “This collaboration reflects our shared commitment to helping researchers work more efficiently and unlock deeper biological insights.”
The partnership reflects DKSH’s continued commitment to expanding its life sciences portfolio and supporting innovation through tailored market expansion strategies that deliver value to partners and customers alike.
About Standard BioTools Inc.
Standard BioTools Inc. has an established portfolio of essential, standardized next-generation technologies that help biomedical researchers develop better medicines faster. As a leading solutions provider, the company provides reliable and repeatable insights in health and disease using its proprietary mass cytometry and microfluidics technologies, which help transform scientific discoveries into better patient outcomes. Standard BioTools works with leading academic, government, pharmaceutical, biotechnology, plant and animal research and clinical laboratories worldwide, focusing on the most pressing needs in translational and clinical research, including oncology, immunology and immunotherapy. www.standardbio.com
About DKSH
For more than 160 years, DKSH has been delivering growth for companies in Asia Pacific, Europe, and North America across its Business Units Healthcare, Consumer Goods, Performance Materials, and Technology. As a leading Market Expansion Services provider, DKSH offers sourcing, market insights, marketing and sales, e-commerce, distribution and logistics as well as after-sales services, following its purpose of enriching people’s lives. DKSH is a participant of the United Nations Global Compact and adheres to its principles-based approach to responsible business. Listed on the SIX Swiss Exchange, DKSH operates in 35 markets with 26,840 specialists, generating net sales of CHF 11.1 billion in 2025. DKSH Business Unit Technology offers complete solutions for specialized scientific and industrial applications. With around 1,770 specialists, the Business Unit generated net sales of CHF 513.5 million in 2025. www.dksh.com/tec

